← Back to Clinical Trials
Recruiting NCT07444021

NCT07444021 Effect of Resistance Exercise on Energy Balance and Appetite Regulation in Males and Females

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07444021
Status Recruiting
Phase
Sponsor National Taiwan Normal University
Condition Energy Balance
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2025-12-01
Primary Completion 2026-12-30

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
resistance exercise (males)resistance exercise (females)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2025-12-01 with a primary completion date of 2026-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

There is growing evidence that males and females may exhibit different acute responses and long-term adaptations to exercise training. Accordingly, contemporary exercise physiology research increasingly recognizes sex as an important biological variable that may influence appetite regulation and energy balance. This year's project aims to investigate: (1) appetite regulation and energy balance following acute resistance exercise, and (2) potential sex-based differences in appetite regulation and energy balance in response to resistance exercise. Understanding both the overall effects of resistance exercise and sex-related variability in these responses is important for improving the physiological interpretation of exercise-induced changes in appetite and energy balance. Such knowledge may help to reduce heterogeneity in exercise research findings and support the development of more precise, evidence-based exercise prescriptions that are applicable to both males and females.

Eligibility Criteria

Inclusion Criteria: * Healthy males and females aged 20-30 years * Females with a regular menstrual cycle * Stable body weight, defined as no significant change in body weight during the past 6 months * Willingness to participate and provide written informed consent Exclusion Criteria: * Obesity, defined as: * Body mass index (BMI) \> 30 kg/m² * Body fat percentage \> 25% in males * Body fat percentage \> 30% in females * Hypertension, defined as resting blood pressure \> 140/90 mmHg * History of cardiovascular disease * History of cancer * History of liver disease * History of kidney disease * Presence of any medical condition that may interfere with study outcomes

Contact & Investigator

Central Contact

Hung-wen Liu, Ph.D.

✉ hwliu@ntnu.edu.tw

📞 +886 0277496863

Frequently Asked Questions

Who can join the NCT07444021 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 30 Years, studying Energy Balance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07444021 currently recruiting?

Yes, NCT07444021 is actively recruiting participants. Contact the research team at hwliu@ntnu.edu.tw for enrollment information.

Where is the NCT07444021 trial being conducted?

This trial is being conducted at Taipei, Taiwan.

Who is sponsoring the NCT07444021 clinical trial?

NCT07444021 is sponsored by National Taiwan Normal University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology